Cooper A, Hannan E L, Bessey P Q, Farrell L S, Cayten C G, Mottley L
Columbia University College of Physicians and Surgeons and Harlem Hospital Center, New York, New York, USA.
J Trauma. 2000 Jan;48(1):16-23; discussion 23-4. doi: 10.1097/00005373-200001000-00004.
New York State Trauma Registry data were analyzed to determine whether there is a significant relationship between the volume of trauma patients treated by a trauma center and its risk-adjusted inpatient mortality rate.
Stepwise logistic regression was used to identify significant independent predictors of mortality, their weights, and the probability of in-hospital mortality for each patient. These data were then used to calculate risk-adjusted mortality rates for various ranges of hospital volume. Ranges were identified on the basis of homogeneity of mortality rates, the number of hospitals in each range, and the number of patients in each range. Three volume measures were used: (1) total annual volume of trauma cases > or = 1200 and total annual volume > or = 240 for patients with Injury Severity Score (ISS) > or = 15 (equivalent to American College of Surgeons [ACS] criteria), (2) total annual volume of patients with ISS > or = 15, and (3) total annual volume of cases in the Registry (approximately, inpatients with ISS > or = 9).
Results show that the 35 New York State trauma centers not meeting the ACS criteria had lower, but not significantly lower, observed and risk-adjusted mortality rates (7.62% and 8.25%, respectively) than the corresponding rates for the 8 New York State trauma centers that met the ACS criteria (9.36% and 8.83%, respectively). Regarding the other two criteria, hospital ranges representing lower annual volumes tended to have somewhat lower, although not significantly lower, observed and risk-adjusted mortality rates. For example, using a total annual volume for patients with ISS > or = 15, the risk-adjusted mortality rates for the volume ranges 1-150, 151-250, and 251+ were 7.78%, 9.23%, and 8.70%, respectively.
We were unable to document an inverse relationship between hospital volume and inpatient mortality rate for trauma centers in New York State. Volume criteria should not be considered indicators of the quality of trauma care.
分析纽约州创伤登记数据,以确定创伤中心治疗的创伤患者数量与其风险调整后的住院死亡率之间是否存在显著关系。
采用逐步逻辑回归来确定死亡率的显著独立预测因素、其权重以及每位患者的院内死亡概率。然后使用这些数据计算不同医院规模范围内的风险调整死亡率。根据死亡率的同质性、每个范围内的医院数量以及每个范围内的患者数量来确定范围。使用了三种规模衡量指标:(1)每年创伤病例总数≥1200例,且损伤严重度评分(ISS)≥15的患者每年总数≥240例(等同于美国外科医师学会[ACS]标准);(2)ISS≥15的患者每年总数;(3)登记处病例的每年总数(大致为ISS≥9的住院患者)。
结果显示,不符合ACS标准的35家纽约州创伤中心的观察到的死亡率和风险调整后的死亡率(分别为7.62%和8.25%)低于符合ACS标准的8家纽约州创伤中心的相应死亡率(分别为9.36%和8.83%),但差异不显著。对于其他两个标准,代表较低年规模的医院范围的观察到的死亡率和风险调整后的死亡率往往略低,但差异不显著。例如,使用ISS≥15的患者每年总数,规模范围为1 - 150、151 - 250和251以上的风险调整死亡率分别为7.78%、9.23%和8.70%。
我们无法证明纽约州创伤中心的医院规模与住院死亡率之间存在反比关系。规模标准不应被视为创伤护理质量的指标。